Genetic variations in APPL2 are associated with overweight and obesity in a Chinese population with normal glucose tolerance
- Shan Jiang†1,
- Qichen Fang†1,
- Weihui Yu1,
- Rong Zhang1,
- Cheng Hu1,
- Kun Dong1,
- Yuqian Bao1,
- Chen Wang1,
- Kunsan Xiang1 and
- Weiping Jia1, 2Email author
© Jiang et al; licensee BioMed Central Ltd. 2012
Received: 8 November 2011
Accepted: 30 March 2012
Published: 30 March 2012
APPL1 and APPL2 are two adaptor proteins, which can mediate adiponectin signaling via binding to N terminus of adiponectin receptors in muscle cells. Genes encoding adiponectin and adiponectin receptors contribute to insulin resistance and the risk of obesity, and genetic variants of APPL1 are associated with body fat distribution. However, the association between genetic variations of APPL2 and metabolic traits remains unknown. In the current study, we aimed to test the impacts of APPL2 genetic variants on obesity in a Chinese population with normal glucose tolerance.
We genotyped six single nucleotide polymorphisms (SNPs) in APPL2 in 1,808 non-diabetic subjects. Overweight and obesity were defined by body mass index (BMI). Obesity-related anthropometric parameters were measured, including height, weight, waist circumference, hip circumference. BMI and waist-hip ratio (WHR) were calculated.
We found significant evidence of association with overweight/obesity for rs2272495 and rs1107756. rs2272495 C allele and rs1107756 T allele both conferred a higher risk of being overweight and obese (OR 1.218, 95% CI 1.047-1.416, p = 0.011 for rs2272495; OR 1.166, 95% CI 1.014-1.341, p = 0.031 for rs1107756). After adjusting multiple comparisons, only the effect of rs2272495 on overweight/obesity remained to be significant (empirical p = 0.043). Moreover, we investigated the effects of these SNPs on obesity-related quantitative traits in all participants. rs2272495 was associated with BMI (p = 0.015), waist circumference (p = 0.006), hip circumference (p = 0.025) as well as WHR (p = 0.047) under a recessive model. Similar associations were found for rs1107756 except for WHR.
This study suggests that genetic variations in APPL2 are associated with overweight and obesity in Chinese population with normal glucose tolerance.
In recent years, the worldwide prevalence of obesity has increased dramatically and has became a major global epidemic impacting on morbidity and mortality. According to data from World Health Organization (WHO), more than 1 billion adults are overweight worldwide and at least 300 million are clinically obese . Although the developments of obesity are mainly attributed to environmental and behavioural factors such as a sedentary habit and overly rich nutrition, multiple genetic components do predispose to this disease, which is suggested by genome-wide association studies (GWAS) and genetic epidemiologic researches . Up to now, GWAS have identified approximately 50 loci associated with obesity .
Adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 (APPL1) and Adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 (APPL2) are two adaptor proteins, which can mediate adiponectin signaling via binding to N terminus of adiponectin receptors in muscle cells [4–6]. They are both highly expressed in insulin-target tissues, including skeletal muscle, liver and adipose tissue [4, 7]. APPL1 and APPL2 were found to share 54% identity in protein sequences and be encoded by gene on human chromosomes 3 and 12, respectively . Our previous study has demonstrated that genetic variants of APPL1 are correlated with body fat distribution in Chinese type 2 diabetic patients . However, to date, there is no study available concerning the association between genetic variations of APPL2 and metabolic traits. Therefore, we investigated the association of APPL2 with obesity and obesity-related quantitative traits in a Chinese non-diabetic population.
Clinical characteristics of study population
57.04 ± 12.76
57.49 ± 11.81
58.50 ± 11.37
21.72 (20.27, 22.81)
25.61 (24.79, 26.64)
29.29 (28.48, 31.04)
Waist circumference (cm)
73.50 (69.00, 78.00)
84.00 (79.00, 89.00)
93.50 (88.00, 98.00)
Hip circumference (cm)
89.00 (85.00, 92.00)
95.50 (93.00, 99.00)
102.00 (99.00, 105.00)
0.83 (0.79, 0.87)
0.88 (0.84, 0.92)
0.91 (0.87, 0.92)
All participants underwent detailed clinical investigations as described previously . In brief, anthropometric parameters, including height, weight, waist and hip circumference were measured in all subjects. BMI was calculated as weight in kilograms divided by the square of height in meters and waist-to-hip ratio (WHR) was calculated as waist circumference (cm)/hip circumference (cm).
Single nucleotide polymorphism (SNP) selection and genotyping
In the present study, we selected six tagging SNPs in APPL2 from the HapMap Phase 3 Chinese population including rs935251, rs10861360, rs1196744, rs1196768, rs3751191 and rs1107756 together with one non-synonymous SNP (rs2272495) in exon15. The figure S1 (see Additional file 1) shows linkage disequilibrium plot of all variants within APPL2 using CHB data of HapMap version 3 Release 27 and highlights the SNPs selected in our study. All the seven SNPs were genotyped by primer extension of multiplex products with detection by matrix-assisted laser desorption/ionisation time-of-flight mass spectroscopy using a MassARRAY platform (MassARRAY Compact Analyzer; Sequenom, San Diego, CA, USA). rs935251 is excluded because of genotyping failure and rs1196744 because of departure from Hardy-Weinberg equilibrium (p = 6.76E-56). The remaining five SNPs could tag 93% SNPs with a minor allele frequency (MAF) of > 0.1 from 18.9 kb upstream to 7.5 kb downstream of APPL2 based on an r2 of ≥ 0.7. The call rates for rs2272495, rs10861360, rs1196768, rs3751191 and rs1107756 were 97.0%, 95.6%, 96.3%, 96.5% and 96.8%, respectively. The concordance rates based on 100 duplicates were over 99% for all these SNPs.
In silico prediction of the functionality of APPL2 SNPs
PolyPhen2 (Polymorphism Phenotyping v2), a revised version of PolyPhen, is a tool which can predict the possible impact of missense mutations on the structure and function of encoded proteins. The prediction is based on performing various sequence and structure analyses. We assessed the functionality of coding variant (rs2272495) using PolyPhen2. The outputs of predictions are cataloged as benign, possibly damaging or probably damaging. PolyPhen2 is available at http://genetics.bwh.harvard.edu/pph2.
χ 2 test was performed to estimate Hardy-Weinberg equilibrium for each variant before association analyses. Pairwise linkage disequilibrium was estimated for all DNA samples via calculating |D'| and r2 using Haploview (version 4.2) . Haplotype block structure was assessed by confidence interval algorithm . Expectation-Maximization algorithm were used to estimated Haplotype frequencies by Haploview (version 4.2) . The allelic and haplotype frequencies were compared using χ 2 tests between overweight and obese subjects and those with normal weight. Odds ratios (ORs) with 95% confidence intervals (CIs) were presented. Associations of SNPs with obesity-related measurements were assessed under a recessive model. Non parametric approach of rank transformation was performed to assess the contrasts results among three genotypes. Skewly distributed quantitative traits, including BMI, waist circumference, hip circumference and WHR were log10 transformed to approximate univariate normality before analysis. For adjusting multiple comparison, 10,000 permutations were performed to assess empirical p values using PLINK (version1.07) . All statistical analyses were performed using SAS for Windows (version 8.0; SAS Institute, Cary, NC, USA) unless specified otherwise. A two-tailed p value < 0.05 was considered significant. We estimated study power using QUANTO. Assuming an additive model with the minor allele frequencies of 0.1, 0.2, 0.3 and 0.4 in our Chinese population, our sample size has 0.53, 0.77, 0.87 and 0.91 power to detect an OR of 1.25 at an α level of 0.05.
Associations of APPL2 SNPs with overweight and obesity
Overweight + Obesity
Empirical p value
p value #
Empirical p value #
Risk allele frequencies
Genotype count 11/12/22a
Risk allele frequencies
Genotype count 11/12/22a
Associations of haplotypes consisting of two SNPs in the APPL2 region with overweight and obesity
Overweight + Obesity
Block 1 (rs1107756 - rs1196768)
Block 2 (rs2272495 - rs10861360)
Association of rs2272495 in APPL2 with obesity-related measures in all participants
TT(n = 131)
CT(n = 706)
CC(n = 915)
Median (interquartile range)
Median (interquartile range)
Median (interquartile range)
TT + CT VS. CC
22.806 (21.197, 24.844)
23.166 (21.193, 25.398)
23.459 (21.502, 25.932)
waist circumference (cm)
77.000 (71.000, 83.000)
78.000 (71.000, 84.000)
79.000 (72.000, 86.000)
hip circumference (cm)
91.000 (87.000, 95.000)
91.500 (87.000, 96.000)
92.000 (88.000, 97.000)
0.849 (0.800, 0.898)
0.849 (0.809, 0.895)
0.857 (0.809, 0.906)
In the present study, we tested five SNPs in APPL2 and identified two novel risk-conferring SNPs, rs2272495 and rs1107756, for overweight and obesity in non-diabetic individuals. We also found these SNPs, especially rs2272495, were associated with obesity-related measures in these subjects.
APPL2 is an isoform of APPL1 and can form a dimer with APPL1 [15, 16]. APPL1 is a critical regulator in both adiponectin and insulin signaling pathway. APPL1, which binds directly to adiponectin receptors (AdipoR1 and AdipoR2), can positively mediate adiponectin signaling and phosphorylate its downstream molecules, leading to increased glucose uptake and fatty acid oxidation in muscle cells. In addition, APPL1 can enhance the synergistic effect of adiponectin on insulin-stimulated Akt phosphorylation and mediate the cross-talk between adiponectin and insulin signaling pathways . Recently, APPL2 has also been suggested to play an important role in adiponectin and insulin signaling as well as the cross-talk between these two pathways. APPL2 can negatively regulate adiponectin signaling by competing with APPL1 in binding to AdipoR1 in muscle cells. Suppression of APPL2 can promote adiponectin-stimulated glucose uptake and fatty acid oxidation . Although, unlike APPL1, APPL2 does not directly interact with the catalytic subunit of PI3-kinase and Akt2 which are key kinases in the PI3-kinase pathway downstream of the insulin receptor [15, 16], APPL2 can suppress insulin signaling by inhibiting the interaction between APPL1 and the components of insulin signaling. Thus, suppression of APPL2 greatly enhanced the sensitizer effect of adiponectin on insulin .
Previously, a link between genes involved in adiponectin signaling and metabolic traits has been suggested by several studies. The adiponectin gene contributes to variances in the plasma adiponectin levels and insulin resistance index and predisposes to obesity and type 2 diabetes [17–19]; the genes encoding adiponectin receptors are associated with insulin resistance, liver fat and the risk of type 2 diabetes [20, 21]; SNPs in APPL1 are found to be correlated with body fat distribution in Chinese patients with type 2 diabetes . Taken together all these findings, it is conceivable that the gene encoding APPL2, which also participates in adiponectin signaling and indirectly mediates insulin signaling, may also exert an effect on metabolic traits. Consistent with this presumption, our study found an association of APPL2 with overweight/obesity in non-diabetic individuals of Han Chinese ancestry, with rs2272495 C allele and rs1107756 T allele conferring a higher risk of being overweight and obese. It should be noted that obesity is a complex disease that affected by multiple genes and environmental factors. The effect of one genetic variant on obesity and obesity-related traits was limited. Therefore, it is convincible that rs2272495 may affect obesity-related traits according to our results in the Table 4. It is tempting to propose that rs2272495 might be a causal variant for overweight/obesity since it is a strong signal detected in our study and a non-synonymous variant which substitutes valine to alanine. Although this variant is predicted to be benign by PolyPhen2, whether it has effect on protein function in vivo remains unknown and should be further elucidated by mechanic studies. The rs2272495 and rs1107756 were in same haplotype block and displayed D' = 0.92 and r2 = 0.55 in our study population. Based on 0.55 r2, it is a relatively strong LD. Thus, the associations observed for the rs1107756 may be a marker to reflect the association signal for rs2272495. Nevertheless, the possibility that other SNPs may be etiological cannot be excluded. The mechanisms underlying the association between APPL2 and obesity are still unclear, and need to be further illuminated by functional studies.
Some limitations should be noted in the present study. Firstly, we tested the same association of the SNP with adiposity multiple times without correcting for these additional tests in the Table 4. In fact, after Bonferroni correction, rs2272495 was still associated with waist circumference (p = 0.024). Secondly, regarding the Table 4, rs2272495 were associated with obesity-related measures. However, when stratifying according to the 3 subgroups (normal weighted, overweight and obese), no significant association was observed in subgroups (see Additional file 5). As the population included in the present study aged all above 40 years old and age factor may influence the prevalence of obesity, the rate of overweight/obese in our manuscript was higher than reports on obesity in China. Actually, the obesity related phenotypes such as BMI presented in our study were skewed distributed. According to these results (Table 4 and see Additional file 5), we cannot draw solid conclusions that rs2272495 were associated with obesity-related measures in our subjects. The associations between rs2272495 and obesity related phenotypes may only reflect the association between rs2272495 and overweight/obesity. Thirdly, although we found associations of rs2272495 and rs1107756 with overweight/obesity and obesity-related measurements, we had not the opportunity to perform a replication another independent sample. Further replications in other cohorts are needed to confirm the influence of genetic variation within this locus on overweight/obesity or metabolic traits in the Chinese population.
Our data suggest that genetic variations in APPL2 are associated with overweight and obesity in the Chinese subjects with normal glucose tolerance. Further investigations are needed to confirm our findings and demonstrate the mechanisms underlying such association.
Single nucleotide polymorphisms
Body mass index
World Health Organization
Genome-wide association studies
Adaptor protein, Phosphotyrosine interaction, PH domain and leucine zipper containing 1
Adaptor protein, Phosphotyrosine interaction, PH domain and leucine zipper containing 2
Oral glucose tolerance test
Minor allele frequency
Adiponectin receptor 1
Adiponectin receptor 2.
This work was supported by grants from Shanghai Municipality for Basic Research (11JC1409600, 08dj1400601 and 10JC1412400), Project of National Natural Science Foundation of China (30971121, 30800617 and 81170735), National 973 Program (2011CB504001), "Chen Guang" Project (09CG07). We are grateful to all participants in this study. We also thank all laboratory staffs at Shanghai Clinical Center for Diabetes for their dedication in our study.
- Kelly T, Yang W, Chen CS, Reynolds K, He J: Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008, 32 (9): 1431-1437. 10.1038/ijo.2008.102.View ArticleGoogle Scholar
- Walley AJ, Asher JE, Froguel P: The genetic contribution to non-syndromic human obesity. Nat Rev Genet. 2009, 10 (7): 431-442. 10.1038/nrg2594.View ArticlePubMedGoogle Scholar
- McCarthy MI: Genomics, type 2 diabetes, and obesity. N Engl J Med. 2010, 363 (24): 2339-2350. 10.1056/NEJMra0906948.View ArticlePubMedGoogle Scholar
- Wang C, Xin X, Xiang R, Ramos FJ, Liu M, Lee HJ, Chen H, Mao X, Kikani CK, Liu F, Dong LQ: Yin-Yang regulation of adiponectin signaling by APPL isoforms in muscle cells. J Biol Chem. 2009, 284 (46): 31608-31615. 10.1074/jbc.M109.010355.View ArticlePubMedPubMed CentralGoogle Scholar
- Mao X, Kikani CK, Riojas RA, Langlais P, Wang L, Ramos FJ, Fang Q, Christ-Roberts CY, Hong JY, Kim RY, Liu F, Dong LQ: APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol. 2006, 8 (5): 516-523. 10.1038/ncb1404.View ArticlePubMedGoogle Scholar
- Miaczynska M, Christoforidis S, Giner A, Shevchenko A, Uttenweiler-Joseph S, Habermann B, Wilm M, Parton RG, Zerial M: APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment. Cell. 2004, 116 (3): 445-456. 10.1016/S0092-8674(04)00117-5.View ArticlePubMedGoogle Scholar
- Mitsuuchi Y, Johnson SW, Sonoda G, Tanno S, Golemis EA, Testa JR: Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2. Oncogene. 1999, 18 (35): 4891-4898. 10.1038/sj.onc.1203080.View ArticlePubMedGoogle Scholar
- Fang QC, Jia WP, Gao F, Zhang R, Hu C, Wang CR, Wang C, Ma XJ, Lu JX, Xu J, Chen HZ, Xiang KS: Association of variants in APPL1 gene with body fat and its distribution in Chinese patients with type 2 diabetic mellitus. Zhonghua Yi Xue Za Zhi. 2008, 88 (6): 369-373.PubMedGoogle Scholar
- Hu C, Wang C, Zhang R, Ng MC, Bao Y, So WY, Ma RC, Ma X, Chan JC, Xiang K, Jia W: Association of genetic variants of NOS1AP with type 2 diabetes in a Chinese population. Diabetologia. 2010, 53 (2): 290-298. 10.1007/s00125-009-1594-2.View ArticlePubMedGoogle Scholar
- Bei-Fan Z: Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Asia Pac J Clin Nutr. 2002, 11 (Suppl 8): S685-693.View ArticleGoogle Scholar
- Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005, 21 (2): 263-265. 10.1093/bioinformatics/bth457.View ArticlePubMedGoogle Scholar
- Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D: The structure of haplotype blocks in the human genome. Science. 2002, 296 (5576): 2225-2229. 10.1126/science.1069424.View ArticlePubMedGoogle Scholar
- Qin ZS, Niu T, Liu JS: Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am J Hum Genet. 2002, 71 (5): 1242-1247. 10.1086/344207.View ArticlePubMedPubMed CentralGoogle Scholar
- Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC: PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007, 81 (3): 559-575. 10.1086/519795.View ArticlePubMedPubMed CentralGoogle Scholar
- Nechamen CA, Thomas RM, Dias JA: APPL1, APPL2, Akt2 and FOXO1a interact with FSHR in a potential signaling complex. Mol Cell Endocrinol. 2007, 260-262: 93-99.View ArticlePubMedGoogle Scholar
- Chial HJ, Wu R, Ustach CV, McPhail LC, Mobley WC, Chen YQ: Membrane targeting by APPL1 and APPL2: dynamic scaffolds that oligomerize and bind phosphoinositides. Traffic. 2008, 9 (2): 215-229.View ArticlePubMedGoogle Scholar
- Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K, Kadowaki H, Hagura R, Akanuma Y, Yazaki Y, Nagai R, Taniyama M, Matsubara K, Yoda M, Nakano Y, Tomita M, Kimura S, Ito C, Froguel P, Kadowaki T: Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes. 2002, 51 (2): 536-540.View ArticlePubMedGoogle Scholar
- Katsuda Y, Asano A, Murase Y, Chujo D, Yagi K, Kobayashi J, Mabuchi H, Yamagishi M: Association of genetic variation of the adiponectin gene with body fat distribution and carotid atherosclerosis in Japanese obese subjects. J Atheroscler Thromb. 2007, 14 (1): 19-26. 10.5551/jat.14.19.View ArticlePubMedGoogle Scholar
- Menzaghi C, Ercolino T, Di Paola R, Berg AH, Warram JH, Scherer PE, Trischitta V, Doria A: A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes. 2002, 51 (7): 2306-2312. 10.2337/diabetes.51.7.2306.View ArticlePubMedGoogle Scholar
- Vaxillaire M, Dechaume A, Vasseur-Delannoy V, Lahmidi S, Vatin V, Lepretre F, Boutin P, Hercberg S, Charpentier G, Dina C, Froguel P: Genetic analysis of ADIPOR1 and ADIPOR2 candidate polymorphisms for type 2 diabetes in the Caucasian population. Diabetes. 2006, 55 (3): 856-861. 10.2337/diabetes.55.03.06.db05-0665.View ArticlePubMedGoogle Scholar
- Stefan N, Machicao F, Staiger H, Machann J, Schick F, Tschritter O, Spieth C, Weigert C, Fritsche A, Stumvoll M, Haring HU: Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia. 2005, 48 (11): 2282-2291. 10.1007/s00125-005-1948-3.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2350/13/22/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.